| Literature DB >> 32235764 |
Claire E Adams1, Stephanie J Dancer2,3.
Abstract
Staphylococcus aureus is an important bacterial pathogen. This study utilized known staphylococcal epidemiology to track S. aureus between patients, surfaces, staff hands and air in a ten-bed intensive care unit (ICU).Entities:
Keywords: Staphylococcus aureus; critical care; hand-touch site; transmission; ventilation
Year: 2020 PMID: 32235764 PMCID: PMC7142875 DOI: 10.3390/ijerph17062109
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Aerial view of ICU (intensive care unit).
Microbial soil categories for five hand-touch sites on ICU.
| Site | No Growth | Scanty Growth | Light Growth | Moderate Growth | Heavy Growth | No. of Hygiene Fails |
|---|---|---|---|---|---|---|
| Infusion Pump | 16 | 47 | 22 | 13 | 2 | 37/100: 37% |
| Cardiac Monitor | 45 | 28 | 16 | 9 | 2 | 27/100: 27% |
| Right Bedrail | 6 | 38 | 17 | 27 | 12 | 56/100: 56% |
| Over-bed Table | 13 | 35 | 33 | 16 | 3 | 52/100: 52% |
| Left Bedrail | 6 | 31 | 26 | 25 | 12 | 63/100: 63% |
MSSA: methicillin-susceptible S. aureus; MRSA: methicillin-resistant S. aureus; hygiene standard for surfaces: <2.5 cfu/cm2 (ref. [6]); average surface fail = 47% (range: 27%–63%).
Figure 2Hand-touch frequency and gross microbial soil for five near-patient sites on ICU. Average hand-touch frequency/site/h following ten observational audits; each site (n = 5) in ten bed spaces was screened on ten occasions; gross microbial soil defined as no. of screens exceeding 12 cfu/cm2; ICU: intensive care unit.
Microbial burden categories for air (active and passive sampling) and hygiene fails according to standards.
|
|
|
|
|
|
|
|
| Air settle | 1 | 19 | 18 | 2 | 0 | 20/40 = 50% |
|
|
|
|
|
|
|
|
| Air sampler | 1 | 6 | 18 | 15 | 0 | 15/40 = 37.5% |
MSSA: methicillin-susceptible S. aureus; MRSA: methicillin-resistant S. aureus; hygiene standard for air (passive): ≤2 cfu/9 cm2 plate/h (ref. [6]); hygiene standard for air (active): <10 cfu/m3 (ref. [7]); overall, 50% passive air samples fail standards; 37.5% active air samples fail standards.
Figure 3Is surface bioburden associated with air bioburden? Agreement between active and passive air sampling and surface bioburden using a range of surface standards from 0–20 cfu/cm2. The X axis shows the percentage pass or fail agreement between active and passive air data for each bioburden standard; the Y axis shows the surface bioburden value in cfu/cm2.
Figure 4Is surface bioburden associated with clinical risk? Total bioburden (5 sites)/bed (cfu/cm2) plotted against % ICU-acquired S. aureus infection (adjusted for bed occupancy) for Beds 2–10 on 10 sampling days. ICU: intensive care unit; MSSA: methicillin-susceptible S. aureus; MRSA: methicillin-resistant S. aureus.
Whole-genome sequencing (WGS) categories and pathways, lineage, sites, intervals (days) and SNP (single-nucleotide polymorphism) differences of S. aureus clusters in a ten-bed ICU during a ten month study.
| WGS Category | Transmission Pathway | Lineage (MLST-CC) | Patients and Sites Involved | Days between Clusters | No. SNP Differences |
|---|---|---|---|---|---|
|
| 1. Autogenous | 8 | Nose & Resp | 2 | <5 |
| 2. Pt ↔ fomite (touch site) | 5 | Pt. 2 Resp, bed 3 → IVP, bed 3 | 3 | <5 | |
| 3. Pt ↔ fomite (touch site) | 5 | Pt. 2 Resp, bed 3 ↔ R/Rail, bed 3 | 3 | <5 | |
| 4. Autogenous | 15 | Nose & Resp | 5 | <5 | |
| 5. Autogenous | 15 | Nose ↔ CLT | 5 | <25 | |
| 6. Autogenous | 22 (MRSA) | Pt. 4 Per & Pt. 4 DRF | 2 | <5 | |
| 7. Autogenous | 22 (MRSA) | Nose & Resp | 2 | 0 | |
| 8. Autogenous | 22 | Nose & Resp | 1 | <5 | |
| 9. Pt ↔ fomite (touch site) | 22 (MRSA) | L/Rail ↔ Pt. 4 Per & Pt. 4 DRF | 1 | <5 | |
| 10. Autogenous | 30 | Resp & Nose | 4 | <5 | |
| 11. Autogenous | 30 | Nose & Resp | 2 | <5 | |
| 12. Autogenous | 30 | Pt. 7 Nose & Pt. 7 Per/Wound | 5 | <5 | |
| 13. Autogenous | 30 | Nose & Wound | 1 | <5 | |
| 14. Autogenous | 45 | Nose ↔ Resp | 1 | <25 | |
| 15. Autogenous | 45 | Nose ↔ Resp | 2 | <5 | |
| 16. Autogenous | 45 | Resp ↔ Nose | 2 | <25 | |
| 17. Autogenous | 45 | Pt. 3 Per ↔ Pt. 3 Wound | 3 | <5 | |
| 18. Air ↔ fomite | 45 | Air, beds 5–7 ↔ L/Rail, bed 7 | 0 | <5 | |
| 19. Fomite ↔ fomite | 45 | Table ↔ CM | 0 | 0 | |
| 20. Autogenous | 7 | Pt. 6 nose ↔ Pt. 6 CLT | 8 | <10 | |
| 21. Autogenous | 34 | Nose ↔ Resp ↔ Thr | 2 | <25 | |
| 22. Autogenous | 59 | Nose ↔ Resp | 5 | <25 | |
| 23. Autogenous | 59 | Nose ↔ Resp | 0 | <25 | |
| 24. Autogenous | 188 | Resp ↔ Nose | 0 | <10 | |
| 25. Autogenous | 121 | Abscess ↔ Nose | 2 | <10 | |
| 26.Staff hand ↔ air | 25 | Hand ↔ Air, beds 5–7 | 43 | <5 | |
| 27. Staff hand ↔ air | 25 | Hand ↔ Air, beds 8–10 | 43 | <5 | |
|
| 28. Pt ↔ Pt | 59 | Wound ↔ Nose & Resp | 2 | <25 |
| 29. Pt ↔ Pt | 1 | Nose ↔ Nose | 4 | <25 | |
|
| 30. Pt ↔ fomite (touch site) | 5 | Resp, bed 2 ↔ L/Rail, bed 2 | 4 | <50 |
| 31. Staff hand ↔ air | 5 | Hand ↔ Settle plate | 50 | <25 | |
| 32. Pt ↔ Pt | 22 (MRSA) | Per ↔ Nose | 161 | <25 | |
| 33. Pt ↔ Pt | 22 (MRSA) | Nose ↔ Nose | 3 | <25 | |
| 34. Fomite ↔ fomite | 30 | L/Rail, bed 4 ↔ Table, bed 7 | 0 | <25 | |
| 1. Autogenous * | 30 | Pt. 5 Nose → Pt. 5 Resp | 1 | N/A | |
| 2. Autogenous * | 45 | Pt. 8 Nose→ Pt. 8 Wound | 4 | N/A | |
| 3. Autogenous * | 1 | Nose → Wound | 0 | N/A | |
| 4. Pt ↔ Pt | 7 | Pt. 6 Nose/CLT → Pt. 9 Resp | 48 | N/A |
Key: ICU = Intensive Care Unit; Pt = patient; Resp = respiratory secretions; DRF = drain fluid; IVP = intravenous pump; CTL = central line site; Per = perineum; L/R Rail = left/right bedrail; CM = cardiac monitor; Thr = throat; N/A = unavailable for spa typing or WGS. * Matching antibiograms included MICs performed using VITEK2™; # these patients were allocated the same bed space on ICU 3 weeks apart. All S. aureus from Pt 6 (including sputum) had matching antibiograms, which were unique within the study. Pt 6 stayed in ICU for 25 days. Pt 9 had eczema and carried an unrelated nasal S. aureus.
Figure 5Transmission pathways of S. aureus on one ICU. ICU: intensive care unit; MSSA: methicillin-susceptible S. aureus; MRSA: methicillin-resistant S. aureus.